Abstract：
Urokinase-type plasminogen activator(uPA) is a potential therapeutic target for cancerXREFX.1 Very recently, we reported a cyclic peptide-based inhibitor(IG-2, CPAYSRYIGC) of murine u PA with high potency and specificity(Ki=6.8 nM).2-3 However, the potency of IG-2 against human uPA(huPA) was much we...
Keyword：
Reprint 's Address：
Email：
Source ：
Year： 2019
Language： Chinese
Cited Count：
SCOPUS Cited Count：
ESI Highly Cited Papers on the List： 0 Unfold All
WanFang Cited Count：
Chinese Cited Count：
30 Days PV： 2
Affiliated Colleges：
